Data for Metabolic Syndrome Plasma Lipidomics (Study ST000663)

(Analysis AN001012)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4
Arachidonic acid 0.7546 0.9676 1.2052 1.0726
CerP 32:1; [M-H]-@5.15 0.9346 0.8383 1.4314 0.7956
CerP 34:1; [M-H]-@5.86 1.1001 0.7276 1.1320 1.0404
CL 70:1; [M-2H](2-)@6.86 1.2098 0.8061 1.1874 0.7967
CL 70:5; [M-2H](2-)@6.08 1.0388 1.0003 1.2084 0.7525
CL 74:1; [M-2H](2-)@7.42 0.9815 1.0044 1.3552 0.6590
CL 74:3; [M-2H](2-)@6.97 1.1283 0.9676 1.0584 0.8457
CL 74:5; [M-2H](2-)@6.61 1.1505 0.8130 1.2915 0.7451
CL 74:7; [M-2H](2-)@6.10 1.0352 0.8676 1.3114 0.7858
CL 78:5; [M-2H](2-)@7.25 0.9233 1.0100 1.0642 1.0026
CL 78:7; [M-2H](2-)@6.72 0.9358 0.9830 1.2592 0.8220
CL 78:9; [M-2H](2-)@6.53 1.0130 0.9096 1.2549 0.8225
CL 82:13; [M-2H](2-)@6.39 0.9636 0.6725 1.5090 0.8549
CL 82:9; [M-2H](2-)@7.10 0.8615 0.8674 1.2815 0.9896
FFA(16:0) 0.9367 0.9418 1.1053 1.0162
FFA(18:0) 0.9952 0.9342 1.1004 0.9703
FFA(18:1) 0.7705 1.0178 1.1440 1.0677
FFA(18:2) 0.7746 0.9931 1.1417 1.0906
FFA(20:0) 1.0812 0.9177 1.0546 0.9465
FFA(20:1) 0.7919 1.0283 1.1760 1.0039
FFA(20:2) 0.7075 0.9943 1.2070 1.0912
FFA(22:0) 1.1326 0.8824 1.0290 0.9560
FFA(22:1) 1.2486 0.8408 1.1387 0.7720
FFA(22:2) 0.8280 0.9817 1.2684 0.9218
FFA(22:3) 0.7403 1.0547 1.2160 0.9889
FFA(24:0) 1.2380 0.8895 1.0094 0.8631
FFA(24:1) 1.0748 0.8147 1.2160 0.8945
FFA(24:2) 0.9411 0.8373 1.3315 0.8901
FFA(24:3) 0.9816 0.7692 1.5258 0.7233
lysoPE 16:0; [M-H]-@1.70 1.2979 0.7633 1.0309 0.9079
lysoPE 18:0; [M-H]-@2.45 1.0694 0.9164 1.1104 0.9037
lysoPE 18:1; [M-H]-@1.87 1.1425 0.8787 1.1652 0.8137
lysoPE 18:2; [M-H]-@1.40 1.1832 0.8864 1.0482 0.8822
lysoPE 20:3; [M-H]-@1.66 1.0294 0.9600 1.0232 0.9874
lysoPE 20:4; [M-H]-@1.38 0.8696 0.9742 1.1238 1.0324
lysoPE 22:4; [M-H]-@1.92 0.8224 1.1529 1.3403 0.6843
lysoPE 22:5; [M-H]-@1.56 0.8620 1.0606 1.0959 0.9815
lysoPE 22:6; [M-H]-@1.33 0.8752 0.8044 1.2781 1.0423
MGDG 22:1; [M-H]-@1.48 0.9970 0.9355 1.1295 0.9380
PA 34:0; [M-H]-@5.19 0.8314 0.8128 1.4005 0.9552
PA 34:0; [M-H]-@6.91 1.2035 0.7115 1.1605 0.9246
PA 34:0; [M-H]-@7.49 0.8989 0.9444 1.2005 0.9562
PA 38:6; [M-H]-@6.11 0.9268 1.1189 0.9238 1.0304
PC 28:0; [M-Ac-H]-@5.23 1.3322 0.7132 1.2425 0.7121
PC 29:0; [M-Ac-H]-@5.57 1.5191 0.7635 0.9731 0.7443
PC 30:0; [M-Ac-H]-@5.96 1.2695 0.8135 1.2376 0.6793
PC 30:1; [M-Ac-H]-@5.40 1.0525 1.0026 1.3050 0.6399
PC 30:2; [M-Ac-H]-@4.91 0.7313 1.0201 1.3443 0.9043
PC 31:0; [M-Ac-H]-@6.26 1.1196 0.9843 0.7402 1.1560
PC 31:1; [M-Ac-H]-@5.76 0.9829 1.1781 1.0527 0.7863
PC 32:0; [M-Ac-H]-@6.58 1.0656 0.8940 1.1723 0.8681
PC 32:1; [M-Ac-H]-@6.08 1.0003 1.0672 1.0927 0.8398
PC 32:2; [M-Ac-H]-@5.59 1.0691 0.9068 1.1848 0.8393
PC 32:3; [M-Ac-H]-@5.15 1.1895 0.8464 1.2914 0.6727
PC 33:0; [M-Ac-H]-@6.79 1.0576 1.2230 0.9287 0.7907
PC 33:1; [M-Ac-H]-@6.42 0.9849 0.9787 1.1190 0.9174
PC 33:2; [M-Ac-H]-@5.96 1.0257 0.9572 1.0724 0.9446
PC 34:0; [M-Ac-H]-@7.16 1.0060 0.9913 1.0044 0.9982
PC 34:1; [M-Ac-H]-@6.62 1.0726 0.9175 1.2036 0.8063
PC 34:1; [M-Ac-H]-@6.69 1.0726 0.9175 1.2036 0.8063
PC 34:2; [M-Ac-H]-@6.21 1.0984 0.9484 1.0927 0.8605
PC 34:3; [M-Ac-H]-@5.76 0.9981 0.9272 1.1715 0.9032
PC 34:4; [M-Ac-H]-@5.55 0.9335 0.9644 1.1835 0.9187
PC 34:5; [M-Ac-H]-@5.14 0.8765 1.2325 1.1446 0.7464
PC 35:1; [M-Ac-H]-@6.99 1.1695 0.9648 0.9727 0.8930
PC 35:2; [M-Ac-H]-@6.54 1.0610 0.9506 1.1129 0.8755
PC 35:3; [M-Ac-H]-@6.11 1.0847 0.9723 0.9298 1.0132
PC 35:4; [M-Ac-H]-@5.93 0.8800 0.9599 1.2504 0.9097
PC 35:5; [M-Ac-H]-@5.49 0.7570 0.8499 1.5714 0.8217
PC 36:1; [M-Ac-H]-@7.26 1.0703 0.9356 1.1091 0.8851
PC 36:2; [M-Ac-H]-@6.82 1.1125 0.9007 1.0926 0.8942
PC 36:3; [M-Ac-H]-@6.40 1.0025 0.9435 1.1263 0.9278
PC 36:4; [M-Ac-H]-@6.08 0.8590 0.9116 1.2480 0.9814
PC 36:5; [M-Ac-H]-@5.66 0.8932 0.8584 1.3335 0.9149
PC 36:6; [M-Ac-H]-@5.45 1.0527 0.8005 1.1995 0.9472
PC 37:2; [M-Ac-H]-@7.17 1.2782 0.8338 0.9928 0.8951
PC 37:3; [M-Ac-H]-@6.73 0.9223 0.8905 1.2808 0.9064
PC 37:4; [M-Ac-H]-@6.52 0.8378 0.9084 1.2727 0.9811
PC 37:5; [M-Ac-H]-@6.03 0.8338 0.8921 1.2458 1.0283
PC 37:6; [M-Ac-H]-@5.82 1.0868 0.8235 1.0311 1.0585
PC 38:2; [M-Ac-H]-@7.43 1.0955 0.9374 1.0310 0.9361
PC 38:3; [M-Ac-H]-@7.06 0.9075 0.9914 1.1498 0.9513
PC 38:4; [M-Ac-H]-@6.75 0.8329 0.8909 1.2537 1.0225
PC 38:5; [M-Ac-H]-@6.33 0.8558 0.9185 1.2487 0.9770
PC 38:5; [M-Ac-H]-@6.55 0.8558 0.9185 1.2487 0.9770
PC 38:6; [M-Ac-H]-@6.01 1.0210 0.8022 1.2232 0.9536
PC 38:7; [M-Ac-H]-@5.54 1.0607 0.8333 1.2162 0.8898
PC 39:4; [M-Ac-H]-@7.09 0.9934 0.9344 1.2899 0.7824
PC 39:5; [M-Ac-H]-@6.62 0.7551 0.9992 1.3232 0.9224
PC 39:6; [M-Ac-H]-@6.40 1.0139 0.8844 1.2495 0.8523
PC 40:3; [M-Ac-H]-@7.61 1.1079 0.9439 1.1257 0.8224
PC 40:4; [M-Ac-H]-@7.30 0.9510 1.0312 1.1349 0.8828
PC 40:5; [M-Ac-H]-@7.04 0.9087 0.9254 1.2035 0.9624
PC 40:6; [M-Ac-H]-@6.72 0.8084 0.9393 1.3661 0.8862
PC 40:7; [M-Ac-H]-@6.25 0.9678 0.7938 1.2450 0.9934
PC 40:8; [M-Ac-H]-@5.79 1.0516 0.8761 1.2525 0.8198
PC 42:10; [M-Ac-H]-@5.73 0.8122 0.9801 1.2399 0.9678
PC 42:2; [M-Ac-H]-@8.50 1.2515 0.9391 0.8961 0.9133
PC 42:4; [M-Ac-H]-@7.97 1.1984 1.0541 0.9396 0.8079
PC 44:4; [M-Ac-H]-@8.45 1.3235 0.9003 1.0088 0.7674
PE 32:1; [M-H]-@6.27 1.1534 1.0123 1.1176 0.7167
PE 33:2; [M-H]-@6.10 0.9756 1.0100 0.9873 1.0271
PE 34:0; [M-H]-@7.27 1.0053 0.9982 1.0007 0.9958
PE 34:1; [M-H]-@6.86 1.1586 0.8916 1.1935 0.7562
PE 34:2; [M-H]-@5.10 1.0572 0.9887 0.9865 0.9676
PE 34:2; [M-H]-@6.43 1.0830 0.8926 1.1920 0.8323
PE 34:3; [M-H]-@6.07 0.9989 1.0891 1.1079 0.8041
PE 35:1; [M-H]-@7.13 1.0908 1.1680 0.9466 0.7946
PE 35:2; [M-H]-@6.72 1.1651 0.9510 0.9384 0.9456
PE 35:4; [M-H]-@6.08 1.1450 1.1435 0.9138 0.7978
PE 36:0; [M-H]-@7.84 0.9449 0.9556 1.0267 1.0728
PE 36:1; [M-H]-@6.69 0.8987 1.0705 1.2231 0.8077
PE 36:1; [M-H]-@7.44 0.9247 1.0838 1.2530 0.7386
PE 36:2; [M-H]-@5.72 1.0007 1.1426 1.0723 0.7844
PE 36:3; [M-H]-@5.24 1.0292 1.1849 1.0251 0.7609
PE 36:3; [M-H]-@6.56 1.1090 0.8663 1.2609 0.7637
PE 36:4; [M-H]-@6.26 1.0347 0.9475 1.2017 0.8161
PE 36:5; [M-H]-@6.04 0.9332 0.8934 1.2683 0.9051
PE 37:4; [M-H]-@6.70 0.8717 0.9663 1.3447 0.8173
PE 38:1; [M-H]-@7.88 0.8379 1.0173 1.1190 1.0258
PE 38:2; [M-H]-@7.58 1.0314 1.2115 1.1326 0.6246
PE 38:3; [M-H]-@7.25 0.8828 1.0431 1.0394 1.0347
PE 38:4; [M-H]-@6.97 0.9268 1.0220 1.0702 0.9811
PE 38:5; [M-H]-@6.55 0.9719 0.9139 1.2796 0.8346
PE 38:6; [M-H]-@6.18 1.0422 0.8045 1.1729 0.9804
PE 40:4; [M-H]-@7.44 0.9180 1.2196 1.0834 0.7790
PE 40:5; [M-H]-@7.11 0.8541 0.9324 1.1107 1.1028
PE 40:6; [M-H]-@6.92 0.9253 0.6652 1.3455 1.0640
PE 40:7; [M-H]-@6.41 0.9984 0.7690 1.3449 0.8877
PG 34:0; [M-H]-@6.40 1.0000 1.0000 1.0000 1.0000
PG 34:2; [M-H]-@5.57 1.1610 1.0345 0.9824 0.8221
PG 36:2; [M-H]-@6.15 0.8100 1.2872 0.9257 0.9771
PG 36:3; [M-H]-@5.43 1.0215 0.9631 1.2102 0.8051
PG 38:4; [M-H]-@6.14 0.8267 1.1040 1.1053 0.9640
PI 34:1; [M-H]-@5.77 1.2224 1.0286 1.0120 0.7370
PI 34:2; [M-H]-@5.37 1.1357 1.0101 0.9696 0.8845
PI 36:1; [M-H]-@6.40 1.1819 0.9619 1.1317 0.7245
PI 36:2; [M-H]-@6.01 1.2316 1.0354 1.0100 0.7229
PI 37:4; [M-H]-@5.66 1.0025 1.0027 0.9980 0.9968
PI 38:3; [M-H]-@6.20 0.9834 1.1519 0.8604 1.0043
PI 38:4; [M-H]-@5.99 1.0074 0.9182 1.1234 0.9510
PI 38:5; [M-H]-@5.48 1.1826 0.9294 0.9502 0.9378
PI 38:6; [M-H]-@5.24 1.3739 0.7325 1.1390 0.7546
PI 40:5; [M-H]-@6.08 0.9068 0.9896 1.3243 0.7793
plasmenyl-PE 32:1; [M-H]-@6.62 0.6529 1.0454 1.3204 0.9814
plasmenyl-PE 34:0; [M-H]-@7.24 1.0248 0.9648 1.1126 0.8978
plasmenyl-PE 34:1; [M-H]-@7.19 0.7570 0.9949 1.1413 1.1068
plasmenyl-PE 34:2; [M-H]-@6.75 0.9148 1.2035 0.9827 0.8990
plasmenyl-PE 34:3; [M-H]-@6.34 0.8858 1.2886 0.8850 0.9406
plasmenyl-PE 36:1; [M-H]-@7.73 0.9318 1.0417 1.0162 1.0104
plasmenyl-PE 36:2; [M-H]-@7.35 1.0737 0.9803 0.9820 0.9640
plasmenyl-PE 36:3; [M-H]-@6.90 1.0236 0.9458 1.0639 0.9667
plasmenyl-PE 36:4; [M-H]-@6.67 0.7518 1.0922 1.2801 0.8759
plasmenyl-PE 36:5; [M-H]-@6.35 0.9622 0.9183 1.3120 0.8075
plasmenyl-PE 38:1; [M-H]-@8.22 1.2367 0.9322 1.0676 0.7634
plasmenyl-PE 38:2; [M-H]-@7.88 1.0733 1.0529 0.9422 0.9316
plasmenyl-PE 38:3; [M-H]-@7.48 1.0358 0.9894 1.0178 0.9570
plasmenyl-PE 38:4; [M-H]-@7.24 0.8720 1.1920 0.9734 0.9626
plasmenyl-PE 38:4; [M-H]-@7.37 0.8720 1.1920 0.9734 0.9626
plasmenyl-PE 38:5; [M-H]-@6.78 0.9219 0.9606 1.2253 0.8922
plasmenyl-PE 38:6; [M-H]-@6.57 0.9010 0.8483 1.3383 0.9124
plasmenyl-PE 40:3; [M-H]-@8.07 0.9473 1.0373 1.0959 0.9196
plasmenyl-PE 40:4; [M-H]-@7.77 0.9173 1.3186 0.9562 0.8079
plasmenyl-PE 40:5; [M-H]-@7.34 1.0013 0.9964 1.0731 0.9293
plasmenyl-PE 40:5; [M-H]-@7.45 1.0013 0.9964 1.0731 0.9293
plasmenyl-PE 40:6; [M-H]-@7.21 1.0380 0.8465 1.1052 1.0103
plasmenyl-PE 42:4; [M-H]-@8.19 1.0933 1.0223 1.1444 0.7399
plasmenyl-PE 42:5; [M-H]-@7.88 1.0124 0.9998 1.1107 0.8771
plasmenyl-PE 42:6; [M-H]-@7.77 1.3076 0.7728 1.1203 0.7992
PS 34:0; [M-H]-@6.36 1.0225 0.9776 0.9971 1.0028
PS 36:1; [M-H]-@6.48 1.1161 1.2867 0.9835 0.6137
PS 38:4; [M-H]-@6.08 1.1081 1.7479 0.5881 0.5558
PS 38:5; [M-H]-@5.64 0.9905 1.4180 0.8294 0.7621
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1control:Control | visit:Control
F2control:Metabolic syndrom | visit:MS Visit 1
F3control:Metabolic syndrom | visit:MS Visit 3
F4control:Metabolic syndrom | visit:MS Visit 4
  logo